Suchergebnisse - "Oluwole, Olalekan O"

PubPharm (4)

1

An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States

enthalten in: Journal of medical economics | 2024

von Oluwole, O. | Patel, A. | Vadgama, S. | +6

2

Matching-adjusted indirect comparison of axi-cel and liso-cel in relapsed or refractory large B-cell lymphoma

enthalten in: Leukemia & lymphoma | 2022

von Oluwole, O. | Chen, J. | Chan, K. | +6

3

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

enthalten in: Journal of hematology & oncology | 2022

von Shah, B. | Ghobadi, A. | Oluwole, O. | +27

4

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

enthalten in: Journal of hematology & oncology | 2022

von Shah, B. | Ghobadi, A. | Oluwole, O. | +27

1
[1]